Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 4962137, 5 pages
https://doi.org/10.1155/2017/4962137
Research Article

Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer

1Clinic of Endocrinological and General Surgery, Chair of Endocrinology, Medical University of Lodz, Pabianicka 62, 93-513 Lodz, Poland
2Department of Immunoendocrinology, Chair of Endocrinology, Medical University of Lodz, Sterlinga 3, 91-425 Lodz, Poland
3Clinic of Endocrinology, Chair of Endocrinology, Medical University of Lodz, Sterlinga 3, 91-425 Lodz, Poland

Correspondence should be addressed to Hanna Ɓawnicka

Received 16 November 2016; Revised 2 January 2017; Accepted 16 January 2017; Published 31 January 2017

Academic Editor: Tomás Sobrino

Copyright © 2017 Tomasz Stępień et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tomasz Stępień, Mateusz Brożyna, Krzysztof Kuzdak, et al., “Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer,” Disease Markers, vol. 2017, Article ID 4962137, 5 pages, 2017. doi:10.1155/2017/4962137